Complimentary Webinar: Feeder-independent growth of hESCs & hiPSCs using mTeSR(R)1
Link
Promise of Nanodiamonds for Safer Gene Therapy
Researchers has introduced the power of nanodiamonds as a novel gene delivery technology that combines key properties in one approach: enhanced delivery efficiency along with outstanding biocompatibility. [Northwestern University, Evanston]
Article
Clemson University Researcher Regenerates Brain Tissue in Traumatic Injuries
An injectable biomaterial gel may help brain tissue grow at the site of a traumatic brain injury, according to recent findings. [Clemson University, Clemson]
Article
Glow-in-the-dark Stem Cells
Monash stem cell scientists have modified a human embryonic stem cell line so that it glows red when the stem cells become red blood cells. [Monash University, Melbourne]
Article
Study Promises Faster Recovery from Life-Threatening Blood Cell Shortages
A key compound resupplies bone marrow with fast-acting stem cells that can more quickly rekindle blood cell production according to a recent study. [University of Rochester, Rochester]
Article
Modeling Diabetes with Stem Cells
A technique that allows the insulin-producing cells that are destroyed by type 1 diabetes to be re-created in the lab could help researchers understand how the disease develops and perhaps lead to more effective treatments for the condition. [Harvard University, Boston]
Article
Two Proteins Enable Skin Cells to Regenerate
Researchers have found that stem cells located within the skin actively generate differentiating cells that can ultimately form either the body surface or the hairs that emanate from it. [The Rockerfeller University, New York]
Article
StemCells, Inc. Demonstrates Protection Of Neurological Function In Batten Mouse
StemCells, Inc. recently announced the publication of preclinical data demonstrating for the first time that transplantation of its proprietary, purified human neural stem cells delays the loss of motor function in a mouse model of infantile neuronal ceroid lipofuscinosis. [StemCells, Inc., Palo Alto]
Article
Joining the Dots on Stem Cell Signaling
Transcription factors, the proteins that control the activity of genes, can be part of a hierarchy of signaling compounds in embyronic stem cells. [RIKEN, Saitama]
Article
Stemedica Achieves Major Milestone – Company Receives License to Manufacture Clinical Grade Stem Cells
Stemedica Cell Technologies, Inc. announced recently that it has been granted a license by the State of California’s Food & Drug Branch to manufacture stem cells for human clinical trials. [Stemedica Cell Technologies, Inc., San Diego]
Article
Safer Bone Marrow Transplants for Sick Children
For the first time, researchers have used antibodies that recognise the bone marrow to prevent rejection and create space for the donor stem cells. [Great Ormond Street Hospital for Children NHS Trust, London]
Article
Cytopia’s CYT387 Receives FDA Clearance to Start US Clinical Trials
Cytopia Limited’s Investigational New Drug Application for CYT387, a small-molecule oral JAK1/JAK2 kinase inhibitor designed to treat various haematological disorders, has passed US Food and Drug Administration review. [Cytopia Limited, Melbourne]
Article
ABSTRACTS, REVIEWS AND SPECIAL REPORTS
Phase III Prospective Randomized Double-Blind Placebo-Controlled Trial of Plerixafor Plus Granulocyte Colony-Stimulating Factor Compared With Placebo Plus Granulocyte Colony-Stimulating Factor for Autologous Stem-Cell Mobilization and Transplantation for Patients With Non-Hodgkin’s Lymphoma
This study evaluates the safety and efficacy of plerixafor, a CXCR4 antagonist, in mobilizing hematopoietic stem cells for autologous stem-cell transplantation in non-Hodgkin’s lymphoma patients. [Journal of Clinical Oncology]
Article
Sox2 is Dispensable for the Reprogramming of Melanocytes and Melanoma Cells into Induced Pluripotent Stem Cells
Here, the researchers show that both human and mouse melanocytes give rise to iPSCs at higher efficiencies than fibroblasts, and mouse malignant melanoma cell line remains equally amenable to reprogramming into iPSCs. [Journal of Cell Science]
Article
Generation and Characterization of Functional Cardiomyocytes using Induced Pluripotent Stem Cells derived from Human Fibroblasts
This paper describes the successful development of both spontaneous and inductive cardiomyocyte differentiation of iPS cells reprogrammed from human foreskin fibroblasts. [Cell Biology International]
Article
Visit our events page to stay up to date with the latest events in the cell, gene and immunotherapy community.
JOB OPPORTUNITIES
Research and Development Scientist – Stem Cell Biology
Recruit Top Talent
Reach more than 11,000 potential candidates by posting your organization’s career opportunities with Cell Therapy News.
Visit here to post your career opportunities.